Veterinary Oncology Market Growth, Size, Trends Analysis- By Animal Type, By Therapy, By Cancer Type - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

Veterinary Oncology Market Introduction and Overview

According to SPER market research, 'Global Veterinary Oncology Market Size- By Animal Type, By Therapy, By Cancer Type - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Veterinary Oncology Market is predicted to reach 5.04 Billion by 2034 with a CAGR 12.36%.

Veterinary oncology is a specialized area of veterinary medicine dedicated to the diagnosis, treatment, and management of cancer in animals. It involves a range of treatment options, including surgery, chemotherapy, radiation, and newer therapies like immunotherapy and targeted treatments. Given that cancer is a major cause of illness and death in companion animals, especially older pets, veterinary oncology is essential for enhancing their quality of life and extending their longevity.

Restraints: The veterinary oncology market faces several challenges that can hinder its growth and accessibility. A major issue is the high cost of cancer treatments, which can be unaffordable for many pet owners, restricting access to essential care. Moreover, there is a shortage of specialized veterinary oncologists and a limited number of advanced treatment centers, especially in rural areas, making it challenging for pet owners to find expert care.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Animal Type, By Therapy, By Cancer Type

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered Elanco, Boehringer Ingelheim International GmbH, Zoetis, Elekta AB, PetCure Oncology, Accuray Incorporated, Varian Medical Systems, Inc. (parent company: Siemens Healthineers), Virbac, Merck & Co., Inc., Ardent Animal Health, LLC.

Global Veterinary Oncology Market Segmentation:

By Animal Type: Based on the Animal Type, Global Veterinary Oncology Market is segmented as; Canine, Feline, Equine.

By Therapy: Based on the Therapy, Global Veterinary Oncology Market is segmented as; Radiotherapy, Surgery, Chemotherapy, Immunotherapy, Other Therapies.

By Cancer Type: Based on the Cancer Type, Global Veterinary Oncology Market is segmented as; Skin Cancers, Lymphomas, Sarcomas, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe and Middle East & Africa.

Product Code: HLCA25153

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Veterinary Oncology Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Veterinary Oncology Market

7. Global Veterinary Oncology Market, By Animal Type, (USD Million) 2021-2034

7.1. Canine
7.2. Feline
7.3. Equine

8. Global Veterinary Oncology Market, By Therapy, (USD Million) 2021-2034

8.1. Radiotherapy
- 8.1.1. Stereotactic Radiation Therapy
- 8.1.2. Conventional Radiation Therapy
8.2. Surgery
8.3. Chemotherapy
8.4. Immunotherapy
8.5. Other Therapies

9. Global Veterinary Oncology Market, By Cancer Type, (USD Million) 2021-2034

9.1. Skin Cancers
9.2. Lymphomas
9.3. Sarcomas
9.4. Others

10. Global Veterinary Oncology Market, (USD Million) 2021-2034

10.1. Global Veterinary Oncology Market Size and Market Share

11. Global Veterinary Oncology Market, By Region, 2021-2034 (USD Million)

11.1. Asia-Pacific
- 11.1.1. Australia
- 11.1.2. China
- 11.1.3. India
- 11.1.4. Japan
- 11.1.5. South Korea
- 11.1.6. Rest of Asia-Pacific
11.2. Europe
- 11.2.1. France
- 11.2.2. Germany
- 11.2.3. Italy
- 11.2.4. Spain
- 11.2.5. United Kingdom
- 11.2.6. Rest of Europe
11.3. Middle East and Africa
- 11.3.1. Kingdom of Saudi Arabia
- 11.3.2. United Arab Emirates
- 11.3.3. Qatar
- 11.3.4. South Africa
- 11.3.5. Egypt
- 11.3.6. Morocco
- 11.3.7. Nigeria
- 11.3.8. Rest of Middle-East and Africa
11.4. North America
- 11.4.1. Canada
- 11.4.2. Mexico
- 11.4.3. United States
11.5. Latin America
- 11.5.1. Argentina
- 11.5.2. Brazil
- 11.5.3. Rest of Latin America

12. Company Profile

12.1. Elanco
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
12.2. Boehringer Ingelheim International GmbH
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
12.3. Zoetis
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
12.4. Elekta AB
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
12.5. PetCure Oncology
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
12.6. Accuray Incorporated
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
12.7. Varian Medical Systems, Inc. (parent company: Siemens Healthineers)
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
12.8. Virbac
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
12.9. Merck & Co., Inc.
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
12.10. Ardent Animal Health, LLC
- 12.10.1. Company details
- 12.10.2. Financial outlook
- 12.10.3. Product summary
- 12.10.4. Recent developments
12.11. Others